Geometry.Net - Authors: Gonzalez Angel

Programming Distributed Fault Tolerant Systems
14 Francisco Guerra Santana , Francisco Javier Miranda González , angel Alvarez , Sergio Arévalo, An Ada Library to Program FaultTolerant Distributed
http://portal.acm.org/citation.cfm?id=269629.269632
Ángel González
Translate this page La Biblioteca de autor dedicada al poeta ovetense Ángel González se ubica dentro de la Biblioteca Virtual Miguel de Cervantes y ofrece una amplia selección
http://www.cervantesvirtual.com/bib_autor/AGonzalez/
Food Mixing By Generalist Grasshoppers Plant Secondary Compounds
Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.
http://www.springerlink.com/index/X27Q356L330861T0.pdf
Business & Technology | Patient In Targeted Genetics Arthritis-drug Trial Dies |
By Ángel González. Seattle Times business reporter. Shortly after suspending a major clinical Ángel González 206515-5644 or agonzalez@seattletimes.com
http://seattletimes.nwsource.com/html/businesstechnology/2003807982_tgen27.html

Extractions: self.name = "parentSection"; The Seattle Times Company NWjobs NWautos NWhomes ... Shopping initnav('timesnav'); initnav('marketplacenav'); Advanced search Movies Restaurants Today's events Hi Contact us Friday, July 27, 2007 - Page updated at 02:04 AM E-mail article Print view Share: Digg Newsvine Seattle Times business reporter Shortly after suspending a major clinical trial because of serious illness in a patient, Targeted Genetics and federal regulators said Thursday that the person had died. Whether it was the experimental arthritis drug being tested that caused the illness is not yet known. But the condition "was related in time to the receipt of a second injection of the product," the U.S. Food and Drug Administration said Thursday in a statement. The agency is investigating whether the illness was related to the treatment. The FDA said it was informed about the death of the patient on Tuesday, the same day Targeted Genetics announced the interruption of the clinical trial in the wake of an "adverse event" for a patient. "We are deeply saddened by the death of an individual enrolled in our clinical trial," Chief Executive H. Stewart Parker said Thursday in a statement.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

81-84 of 84 Back | 1 | 2 | 3 | 4 | 5